Home > Insider Trading > Filing (0001209191-21-036624)

Filing Details

Accession Number:: 0001209191-21-036624
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-28 18:00:27
Reporting Period:: 2021-05-27

Accepted Time:: 2021-05-28 18:00:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1299430	D Christopher Alafi	C/O Alafi Capital Company, Llc 8 Admiral Drive, Suite 324 Emeryville CA 94608		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-27	8,482	$40.01	133,843	No	4	S	Indirect	Held by Christopher D Alafi Family Trust
Common Stock	Disposition	2021-05-28	38,843	$40.12	95,000	No	4	S	Indirect	Held by Christopher D Alafi Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by Christopher D Alafi Family Trust
No	4	S	Indirect	Held by Christopher D Alafi Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	346,795	Direct
Common Stock	4,743,770	Indirect	Held by Alafi Capital Company, LLC
Common Stock	503,753	Indirect	Held as Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Shireen Michele Alafi is the Trustee of the Christopher D Alafi Family Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.005 to $40.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Dr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Dr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
Dr. Alafi is the Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.